Anti-obesity drugs for FDA approval

by Medindia Content Team on  January 18, 2006 at 4:09 PM Obesity News
RSS Email Print This Page Comment bookmark
Font : A-A+

Anti-obesity drugs for FDA approval
Two obesity reducing drugs are awaiting FDA approval and if approved could provide the pharmaceutical manufactures with high profits due to sales of these drugs. These new drugs are to be reviewed by the federal regulators before it could be available as a counter sales drug. Acomplia and Alli are the two new anti-obesity drugs and could help in weight loss management.

Acomplia is manufactured by Sanofi-Aventis and the drug acts by controlling the brain signals which triggers signals for controlling appetite and stimulation to eat more. Alli is produced by GlaxoSmithKline which acts by controlling the body's fat absorption leading to weight loss, Alli is available in drug market under the trade name of xenical, which on clinical trials was found not to cause any adverse effects and was found to reduce 12.4 pounds of weight on an average six months of taking the drug.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Drugs Banned in India 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive